Skip to main content

Table 4 Operating data, intra- and postoperative complications

From: The potential for de-escalation radical surgery in women with stage IB2 cervical cancer (FIGO 2018): a multi-institutional experience of 63,926 cases over a 14-year period in China

 

Before Matching

 

After Matching

Type B Group

(n = 840,%)

Type C Group

(n = 468, %)

P

Type B Group

(n = 688,%)

Type C Group

(n = 445, %)

P

Operating data,

mean (range)

       

Operating time (min)

186.6

(68.0-385.0)

219.9

(65.0-510.0)

< 0.001

 

187.3

(68.0-385.0)

221.5

(86.0-510.0)

< 0.001

Blood loss (mL)

337.7

(30.0-2200.0)

383.0

(20.0-2500.0)

< 0.001

 

350.4

(30.0-2200.0)

381.0

(20.0-2500.0)

0.003

Anal exhaust

time (days)

2.9(1.0–7.0)

2.9(1.0–7.0)

0.246

 

2.9(1.0–7.0)

2.9(1.0–7.0)

0.217

Intestinal Function Recovery (days)

4.1(1.0–9.0)

4.5(1.0–14.0)

< 0.001

 

4.1(1.0–9.0)

4.5(1.0–14.0)

0.001

Removal of catheter (days)

9.1(3.0–36.0)

11.3(5.0–42.0)

< 0.001

 

9.2(3.0–36.0)

11.3(5.0–42.0)

< 0.001

Hospitalization days

12.1(6.0–30.0)

16.2(10.0–26.0)

< 0.001

 

12.0(6.0–29.0)

15.6(10.0–26.0)

0.002

Any one complication

68(8.1)

62(13.2)

0.003

 

58(8.4)

55(12.4)

0.031

Intraoperative complication

3(0.4)

1(0.2)

0.652

 

2(0.1)

1(0.2)

0.833

Major vascular injury

0(0.0)

0(0.0)

-

 

0(0.0)

0(0.0)

-

Ureteral injury

2(0.2)

1(0.2)

0.929

 

1(0.1)

1(0.2)

0.932

Bladder injury

1(0.1)

0(0.0)

0.455

 

1(0.1)

0(0.0)

0.421

Bowel injury

0(0.0)

0(0.0)

-

 

0(0.0)

0(0.0)

-

Postoperative complication

66(7.9)

61(13.0)

0.002

 

57(8.3)

54(12.1)

0.033

Hemorrhage

1(0.1)

0(0.0)

0.455

 

1(0.1)

0(0.0)

0.421

Infection

7(0.8)

2(0.4)

0.395

 

3(0.4)

2(0.4)

0.974

Deep vein thrombosis

5(0.6)

6(1.3)

0.192

 

4(0.6)

4(0.9)

0.533

Bowel obstruction

9(1.1)

3(0.6)

0.434

 

8(1.2)

3(0.7)

0.413

Abdominal incision healing bad

6(0.7)

4(0.9)

0.780

 

5(0.7)

3(0.7)

0.918

Vesicovaginal fistula

0(0.0)

0(0.0)

-

 

0(0.0)

0(0.0)

-

Ureterovaginal fistula

0(0.0)

0(0.0)

-

 

0(0.0)

0(0.0)

-

Rectovaginal fistula

0(0.0)

0(0.0)

-

 

0(0.0)

0(0.0)

-

Chylous leakage

0(0.0)

0(0.0)

-

 

0(0.0)

0(0.0)

-

Lymphedema

1(0.1)

1(0.1)

0.675

 

1(0.1)

1(0.2)

0.756

Lymphocyst

19(2.3)

21(4.5)

0.025

 

17(2.5)

19(4.3)

0.092

Urinary retention

22(2.6)

30(6.4)

<0.001

 

22(3.2)

28(6.3)

0.013